Newly released documents show JPMorgan bankers maintained ties with Jeffrey Epstein years after he was dropped as a client.
Archives
Donald Trump Announces Government Ban on Anthropic Technology Amid Pentagon Dispute
President Donald Trump orders federal agencies to stop using Anthropic's AI technology amid a heated Pentagon dispute over military safeguards.
Paramount–Warner Bros. Discovery Merger Set to Reshape Global Entertainment
Paramount's $110 billion acquisition of Warner Bros. Discovery aims to create a global streaming and entertainment powerhouse.
OpenAI Fires Employee Over Alleged Polymarket Insider Trading
OpenAI fired an employee for allegedly using confidential information to trade on Polymarket, intensifying scrutiny over insider activity in prediction markets.
Walmart Delivery Pay Dispute Ends With $100M Agreement
Walmart will pay $100 million to settle claims of misleading delivery drivers about pay and tips.
Latest News
Oregon Potato Company recalls 55,000 pounds of frozen blueberries due to potential Listeria contamination, posing serious health risks.
Massachusetts couple settles lawsuit against eBay after former employees harassed them with threats and bizarre deliveries.
MrBeast employee fined and suspended by Kalshi for insider trading on video outcome bets.
Japan's Fair Trade Commission raids Microsoft Japan over alleged cloud service restrictions amid global antitrust scrutiny.
Bill Gates apologizes for bringing Gates Foundation executives to meetings with Jeffrey Epstein, admitting it was a mistake.
Gates addresses his controversial ties with Epstein, apologizes for past mistakes, and clarifies position on affairs and philanthropy at town hall.
The release of Jeffrey Epstein's files has sparked renewed scrutiny of tech figures like Steve Jobs and Bill Gates, revealing hidden ties and unverified claims.
Colgate defends its DEI board guidelines, urging investors to reject a conservative proposal to remove diversity criteria.
Novo Nordisk will cut Wegovy and Ozempic prices by up to 50% in 2027 to compete with Eli Lilly and expand patient access.
